Legend Biotech Corp (STU:9LB)
€ 34 -5 (-12.82%) Market Cap: 6.24 Bil Enterprise Value: 5.41 Bil PE Ratio: 0 PB Ratio: 5.89 GF Score: 60/100

Legend Biotech Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 10:15PM GMT
Release Date Price: €53.5 (+2.88%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan and we're continuing the healthcare conference today with Legend Biotech. I'm joined on stage by the company's CEO, Ying Huang. And he's going to give a presentation on the business and then we're going to go into some Q&A. Anyone in the room, you can raise your hand to ask a question, someone will bring you a microphone, or if you have questions you want to submit on the portal, you can do that too.

So with that, let me pass it over to Ying.

Ying Huang
Legend Biotech Corporation - CEO & Director

Thank you, Jess, and I want to also thank JPMorgan for inviting Legend for this conference.

So with that, I'm going to give a very brief overview of the company's operation and then we'll go into Q&A with Jess and anyone, feel free to post questions from the room.

So first, standard disclaimer. We are a public trading company and we are going to make some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot